ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements
Venmax Drugs and Pharmaceuticals held its 37th Annual General Meeting on September 26, 2026. Shareholders considered the financial statements and various directorship appointments.
Venmax Drugs and Pharmaceuticals Limited announced an NCLT-convened meeting of equity shareholders on October 24, 2026, to consider the proposed merger with Hatri Pharma Private Limited.
NCLT Hyderabad directed Venmax to convene a shareholder meeting on 24 Oct 2026 for the amalgamation of Hatri Pharma into Venmax. The order also dispensed with meetings of Hatri Pharma's shareholders and creditors.
Venmax Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹2.5 Cr (+108.3% YoY) and net profit of ₹0.1 Cr for Q1 FY27.
Venmax Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹3.9 Cr (+1200.0% YoY) and net profit of ₹0.1 Cr (-87.5% YoY) for Q4 FY26.